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Background: While the association of ECG markers such as heart rate turbulence (HRT), deceleration capacity (DC) and morphologic variability 
(MV) with death following non-ST-elevation acute coronary syndrome (NSTEACS) has been extensively studied, there is limited data regarding the 
relationship among these metrics and heart failure (HF) post-NSTEACS.
Methods: HRT, DC and MV were calculated in 4,557 patients from the MERLIN-TIMI 36 trial using the first 24 hours of ECG after randomization. DC 
and MV were assessed in all 4,557 patients while HRT was measured in 3,873 patients with premature ventricular contractions. For each measure, 
patients were partitioned into risk groups using cutpoints chosen from the literature (HRT categories 0 [n=2,266], 1 [n=1,206] and 2 [n=401]; DC 
categories 0 [n=3,024], 1 [n=1,126] and 2 [n=407]; MV categories 0 [n=2,673], 1 [n=1,496], and 2 [n=388]).
Results: There were 187 cases of HF during median 1-year follow-up. Each ECG variable was associated with HF on univariate analysis and in 
multivariate models with the TIMI risk score and left ventricular ejection fraction (LVEF) included (Table). The model constructed using the TIMI risk 
score and LVEF (AUC 0.78) showed improved discrimination when all three ECG variables were added (AUC 0.84).
Conclusions: ECG markers may provide supplemental value in risk stratification for HF in patients post-NSTEACS. These metrics may therefore be 
clinically useful in identifying patients requiring more intense monitoring or therapy.
 
